A consortium led by healthcare-focused Quadria Capital has invested in Indian topical drugs maker Encube Ethicals, facilitating an exit for Multiples Alternate Asset Management.
Direct secondaries specialist NewQuest Capital has acquired Indian animation studio Cosmos-Maya from Emerald Media, an Asian media platform backed by KKR.
NewQuest Capital Partners is exiting Integreon, a business process outsourcing (BPO) provider with a significant Asia footprint to US private equity firm EagleTree Capital.
ChrysCapital has exited Silicon Valley-based Infogain – an IT services provider that helped solidify the US-India cross-border opportunity set – to Apax Partners.
Advent International has offloaded its final 5.4% holding in Crompton Greaves’ India-listed household appliances business, ending a gradual exit after a failed takeover.
The Carlyle Group has sold more than two-thirds of its remaining stake in India-listed life insurance company SBI Life for approximately INR39.4 billion ($536 million) via a bulk transaction.
KKR has agreed to acquire New Zealand premium pet food maker Natural Pet Food Group (NPFG) from local private equity firm Pioneer Capital.
Chinese video-streaming platform Bilbili has won the hearts, minds, and wallets of users amid an intensifying content-based battle. Loyal Valley Capital picked an opportune time to make a partial exit
Tokyo-listed accounting software provider Freee is set to raise up to JPY42.5 billion ($391 million) through an offering of new shares and the sale of shares held by DCM Ventures.
The Carlyle Group has sold approximately one-quarter of its remaining 15.8% stake in SBI Cards & Payment Services – a year after the Indian company’s IPO – for INR39.4 billion ($543 million).
The secret to Morgan Stanley Private Equity Asia’s 148x return on dairy producer China Feihe was having faith both in the baby care industry and in a quality domestic brand
CITIC Capital is exiting its stake in business intelligence database provider ISI Emerging Markets Group to UK-based Montagu Private Equity.
Private equity exits – outside of the public markets – are gradually emerging from a COVID-19 hibernation. But sellers must be mindful of timing, structure, and which buyers they are targeting
The Blackstone Group has made a partial exit from Indian packaging manufacturer Essel Propack (EPL) – which provides the tubes to 40% of the world’s toothpaste – generating proceeds of INR18.6 billion ($253.4 million).
Warburg Pincus will sell an approximately 5.5% interest in Hong Kong-listed IVF services provider Jinxin Fertility for about HK$1.5 billion ($194 million) through a share placement.
The Carlyle Group has sold 6.5 million shares of Metropolis Healthcare for INR7.5 billion ($98.7 million) to exit nearly its entire position in the Indian medical diagnostics chain.
China's securities regulator has revised rules on public market sell-downs, making it easier for PE and VC investors to exit their positions in portfolio companies post-IPO.
TPG Capital has generated proceeds of approximately A$66.9 million ($44.3 million) through a partial exit from Australian poultry producer Inghams Group, paring its stake to below 10%.
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.
The Carlyle Group has made a partial exit from India-listed life insurance company SBI Life, selling one-third of its stake for approximately INR28.2 billion ($392 million).
Malaysian sovereign wealth fund Khazanah Nasional has agreed to sell the Prince Court Medical Centre in Kuala Lumpur to local operator IHH Healthcare for about MYR1 billion ($244 million).
US-based private equity firm JC Flowers is planning to sell nearly all of its stake in Japanese financial institution Shinsei Bank for an undisclosed amount.
Southeast Asia’s internal growth and rising appeal among global investors in recent years have fed expectations that PE and VC exits will follow. The logic is sturdy but detailed projections are elusive
VIG has agreed to make a full exit from Korean camera lens manufacturer Samyang Optics – having taken the business public in 2017 – and will realize a 3.5x gross return on its investment.